Telix pays $3.3B to lock up the market

Australian radiopharmaceutical giant Telix is buying privately-owned German radiopharma ITM for up to $3.29 billion, in a deal that leaves current ITM holders with 23.7 per cent of the resulting company.

To see the whole article please log in.

James Quintana Pearce

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here